| GENEREX BIOTECH (NASDAQ:GNBT) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $0.59 | 52 Week High | $1.14 | ||
| Open | $0.61 | 52 Week Low | $0.08 | ||
| Day High | $0.61 | P/E | N/A | ||
| Day Low | $0.58 | EPS | $-0.26 | ||
| Volume | 981,601 | ||||
| More GNBT Info: Chart SEC Filings Profile Historical Options | |||||
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| HEB | 7 | AVII | 6 |
| NVAX | 6 | BCRX | 6 |
| CLDX | 6 | HEB | 6 |
| AVII | 5 | CVM | 5 |
| NVAX | 5 | BCRX | 5 |
| SVA | 5 | GSK | 5 |
No comments are currently available.
on Jan 25, 2010
at 06:58 PM Gnbt This is a great company! A cure for Cancer and the U.S. won't approve it?
Article: Generex Biotech (GNBT) Announces Crave-NX Diet Spray To Be Available at 256 Duane's Locations
on Jan 9, 2010
at 10:59 PM gnbt/crave-nx just a small part of a bigger picture this company has so many different project in the works and crave-nx is just to fund the bigger picture get some now or miss the ship not the boat!
Article: Generex Biotech (GNBT) Announces Crave-NX Diet Spray To Be Available at 256 Duane's Locations
on Dec 18, 2009
at 06:28 PM this artical was updated nextday there were 0 of 49 relapse's in the Ae37 part of the trial arm compared to 5 of 71 in the comparative arm of the phase II trial. the treatment arm of the trial had 2 parts the Ae37 peptide and the other,a gp2 peptide
Article: Generex Biotech (GNBT) Presents Interim Phase II Immunotherapeutic Vaccine Results at SABCS
on Dec 17, 2009
at 08:38 AM YES They CAN.... All the best to AF...Cramer and The Street for this end of Year... AF...If you have some...You would can pay Champaign... P
Article: Generex MENA Supplies Products to New International Territories
on Dec 15, 2009
at 04:07 AM Malinda you are absolutely right... Malinda...I fully agree with your analysis... Thks for all...
Article: Generex Presents Encouraging Interim Results of Phase II Breast Cancer Study